Vasamed, Inc.
VSMD · OTC
12/31/2005 | 12/31/2004 | 12/31/2003 | 12/31/2002 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 29.7% | -49.7% | 34.9% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -5% | -29.8% | 14.9% | 73.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -330% | -568.1% | -103.4% | -110.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -352.6% | -600.7% | -107.4% | -117.6% |
| EPS Diluted | -1.31 | -1.85 | -0.71 | -0.67 |
| % Growth | 29.2% | -160.6% | -6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |